CONTACT
Exciting News! We’ve partnered with Affirm and CareCredit to offer flexible payment plans, making early cancer detection even more accessible.
We now accept 
, Medicare, Medicaid, and most PPO plans.
Exciting News! We’ve partnered with Affirm and CareCredit to offer flexible payment plans, making early cancer detection even more accessible.
We now accept , Medicare, Medicaid, and most PPO plans.
Dr. Phoutthasone Thirakul is a highly accomplished and respected physician specializing in pathology and forensic medicine. She holds a Bachelor of Arts in Psychology with a concentration in Neural and Behavioral Sciences from Bryn Mawr College. She earned her Doctor of Medicine degree from the University of California, San Diego, and completed a prestigious fellowship in Forensic Pathology at the University of South Florida.
Dr. Thirakul is double board-certified in Anatomic and Clinical Pathology and also holds board certification in Forensic Pathology. Licensed as a Medical Doctor by both the Florida and California Departments of Health, she brings a wealth of clinical and investigative expertise to her role.
As Laboratory Director, Dr. Thirakul oversees all clinical and operational aspects of the laboratory, ensuring compliance with regulatory standards and maintaining the highest levels of diagnostic accuracy and quality control. She is responsible for supervising test validations, guiding laboratory personnel, reviewing complex cases, and implementing innovative methodologies that enhance patient care and diagnostic precision.
An active member of the American Academy of Forensic Sciences and the Florida Association of Medical Examiners, Dr. Thirakul remains at the forefront of her field. She has authored numerous peer-reviewed publications, contributing to the advancement of forensic and clinical pathology.
With a deep commitment to scientific integrity and patient-centered care, Dr. Thirakul plays a critical role in shaping the laboratory’s mission to deliver timely, reliable, and personalized diagnostic insights.
Jahmar Hudson is an accomplished clinical scientist with extensive expertise in molecular diagnostics, pharmacogenomics, and laboratory science. His academic foundation includes a Bachelor of Biotechnology in Laboratory Science from Miami Dade College, a Master of Pharmacy in Pharmacogenomics and Personalized Medicine from the University of Cincinnati. He is presently pursuing a Doctorate in Pharmaceutical Sciences with a concentration in Molecular Medicine and Pharmacogenomics at Nova Southeastern University.
Mr. Hudson holds professional certifications as a Molecular Diagnostics Technologist and Laboratory Consultant through the American Medical Technologists, AMT, and a Molecular Technologist through the American Society for Clinical Pathology, ASCP. He is likewise in the process of obtaining a certification in Cytogenetics from ASCP. Additionally, he is licensed by the Florida Department of Health as a Technical Supervisor in Molecular Pathology and is a certified Basic Life Support Provider through the American Heart Association.
In his capacity as Chief Scientific Officer and Technical Supervisor, Mr. Hudson is responsible for the scientific leadership and technical oversight of the laboratory’s molecular diagnostics division. His duties encompass assay development and validation, regulatory compliance, quality assurance, and staff supervision. He plays a pivotal role in the implementation of innovative diagnostic methodologies and ensures the integration of current scientific advancements into clinical practice.
Mr. Hudson also leads educational and training initiatives across multiple franchise laboratory locations. He provides formal instruction, conducts professional lectures, and oversees the standardization of technical protocols to maintain uniform excellence in diagnostic testing. His commitment to academic dissemination supports the development of future laboratory professionals and enhances the scientific capacity of affiliated institutions.
An active participant in ongoing research, Mr. Hudson focuses on areas such as pharmacogenomic profiling, molecular mechanisms of drug response, and the development of precision diagnostic tools. His work contributes to the broader understanding of personalized medicine and the role of molecular science in contemporary clinical care.
Through a combination of scholarly inquiry, technical acumen, and strategic leadership, Jahmar Hudson advances the mission of precision diagnostics and fosters a culture of scientific excellence within the laboratory and beyond.
Stephanie Altidort is a laboratory professional with a strong academic foundation and technical expertise in molecular diagnostics and genomic science. She earned her Bachelor of Science in Neuroscience from Florida Atlantic University, where she developed a foundational understanding of neurobiological processes and cellular mechanisms relevant to molecular medicine. She holds certification as a Molecular Diagnostics Technologist through the American Medical Technologists and is currently pursuing board certification in Cytogenetics through the American Society for Clinical Pathology. Ms. Altidort is licensed as a Florida Supervisor in Molecular Pathology by the Florida Department of Health and maintains certification in Basic Life Support through the National CPR Foundation.
In her role as General Supervisor, Ms. Altidort is entrusted with critical responsibilities aligned with Clinical Laboratory Improvement Amendments (CLIA) regulatory standards. She provides direct supervision of high-complexity molecular testing procedures, ensuring the integrity and validity of all phases of laboratory operations. Her responsibilities include reviewing and authorizing test procedures, monitoring quality assurance and quality control systems, and validating instrument performance to uphold analytical accuracy and reproducibility.
Ms. Altidort plays an integral role in personnel management, including the evaluation of staff competency, coordination of continuing education, and oversight of protocol adherence. She collaborates with the laboratory director and technical leadership in the implementation of new assays, assessment of workflow efficiency, and maintenance of documentation required for regulatory compliance and laboratory accreditation.
With a commitment to scientific rigor and operational excellence, Ms. Altidort advances the quality of diagnostic services through precise supervision, regulatory expertise, and a focus on clinical impact. Her contributions are essential to maintaining the laboratory’s adherence to best practices and its mission of delivering accurate, timely, and clinically actionable results.
Through a combination of scholarly inquiry, technical acumen, and strategic leadership, Jahmar Hudson advances the mission of precision diagnostics and fosters a culture of scientific excellence within the laboratory and beyond.
Stephanie Lucce is a credentialed molecular technologist with specialized training in biotechnology and molecular pathology. She earned her Bachelor of Science in Biotechnology from Miami Dade College, where she acquired a rigorous foundation in molecular biology, genetic analysis, and laboratory methodologies central to clinical diagnostics. She is certified as a Molecular Diagnostics Technologist through the American Medical Technologists and holds licensure as a Technologist in Molecular Pathology from the Florida Department of Health. Additionally, Ms. Lucce is a certified Basic Life Support Provider through the American Heart Association.
In her role as a Molecular Technologist within a clinical genetics laboratory, Ms. Lucce is responsible for the execution of high-complexity molecular assays, including nucleic acid extraction, amplification techniques such as PCR, and the interpretation of molecular signatures associated with genetic and infectious diseases. She ensures the accuracy, sensitivity, and specificity of laboratory results through stringent adherence to standard operating procedures, quality control protocols, and regulatory guidelines.
Ms. Lucce actively contributes to the laboratory’s diagnostic mission by supporting assay development and validation efforts, participating in proficiency testing, and maintaining comprehensive documentation to ensure CLIA compliance. Her work plays a pivotal role in delivering precise and timely molecular data essential to patient care, personalized medicine, and genetic risk assessment.
Through her technical competence, commitment to laboratory excellence, and adherence to scientific standards, Stephanie Lucce advances the quality and reliability of molecular diagnostic services in a dynamic and evolving healthcare environment.
William Wysock is a seasoned molecular scientist with over two decades of experience in clinical and translational research, specializing in molecular diagnostics and infectious disease biology. He holds a Bachelor of Arts in Writing from Loyola University of Maryland and a Master of Science in Biology from the Catholic University of America. His unique interdisciplinary background combines scientific rigor with clear, analytical communication, a valuable asset in both research and laboratory operations.
Mr. Wysock is certified in Molecular Biology by the American Society for Clinical Pathology and has extensive expertise in advanced molecular methodologies, including polymerase chain reaction (PCR) techniques, next-generation sequencing (NGS), and the implementation of laboratory quality systems. He is also trained in Six Sigma methodologies and holds a Green Belt certification, underscoring his commitment to operational efficiency and process improvement.
In his role as Molecular Scientist, Mr. Wysock is principally responsible for overseeing the laboratory’s validation processes. This includes designing and executing method verification studies, analyzing performance metrics, and ensuring all assays meet stringent analytical and clinical standards prior to implementation. His in-depth knowledge of assay development and regulatory requirements plays a critical role in maintaining the scientific credibility and compliance integrity of the laboratory.
Mr. Wysock also serves as the laboratory’s primary resource for complex technical inquiries. He provides expert guidance on molecular workflows, troubleshooting protocols, and optimizing assay performance, thereby supporting both day-to-day operations and long-term innovation. His leadership in this capacity ensures that laboratory personnel are equipped with the technical insights necessary for high-complexity testing.
A prolific contributor to the scientific literature, Mr. Wysock has authored numerous peer-reviewed publications in the fields of molecular diagnostics and infectious disease research. His scholarly work reflects a sustained commitment to advancing laboratory science and integrating evidence-based practices into clinical diagnostics. Through his analytical acumen, mentorship, and research-driven approach, William Wysock significantly enhances the laboratory’s capacity for precision medicine and scientific advancement.